Canadians View Psilocybin Therapy As 'Reasonable Medical Choice' For End-Of-Life Distress, New Study Reveals
A vast majority of Canadians believe that psilocybin-assisted therapy is a reasonable medical option for people experiencing existential distress at the end of life, according to a recent survey. The study, conducted by a team of 12 experts and published in the journal Palliative Care, found that 79.3% of respondents considered the therapy a valid choice for those in the final stages of life. The survey also revealed that 84.8% of Canadians believed the costs of such interventions should be covered by the public health system, while 63.3% supported the legalization of psilocybin for medical purposes. The study, based on 2,800 complete questionnaires collected from four provinces in Canada, highlights the growing acceptance and interest in psychedelic therapies as a potential tool to address end-of-life distress.